Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-03-03 @ 4:14 AM
Study NCT ID:
NCT02436551
Status:
COMPLETED
Last Update Posted:
2019-02-27
First Post:
2015-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gestational Diabetes in Central Asia: Prevalence and Management
Sponsor:
Ludwig-Maximilians - University of Munich
Organization:
Study Overview
Official Title:
Gestational Diabetes in Central Asia: Prevalence and Management
Status:
COMPLETED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GESDICA
Brief Summary:
Evaluate prevalence and management of gestational diabetes in Tajikistan in two different settings (one rural and one urban).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: